Voir la source de Avoid The Top 10 Mistakes Made By Beginning Xarelto Lawsuit

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical companies, such as the makers of Xarelto, possess a duty to ensure that their drugs are reasonably secure for use - and failure to perform so could be grounds for compensation. Our lawyers are operating challenging to get these hurt by the drug the compensation they are entitled to.<br><br>Whilst bleeding is really a common complication associated with anticoagulants, it has been alleged that Xarelto is a lot more harmful than traditional blood [http://Www.Twitpic.com/tag/thinners thinners] due to the fact no [http://www.estateguideblog.com/?s=antidote%20exists antidote exists] to reverse its blood-thinning effects. [https://tortlawyers.s3.amazonaws.com/categories/Xarelto-Lawsuit-Attorneys-in-Georgia/index.html try this website] indicates that, within the event of an emergency, sufferers may possibly be at risk for irreversible bleeding difficulties, like life-threatening internal and gastrointestinal hemorrhaging.<br><br>In the event you or perhaps a loved 1 suffered a critical bleeding occasion following taking Xarelto, you may have legal recourse. For more info, make contact with us today to have your case reviewed, free of charge of charge.<br>Compensation Possibilities<br><br>xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for past and future medical bills, lost wages, pain and suffering and, in instances of death, funeral expenses. Furthermore, they are looking for punitive damages, that are typically awarded to punish the defendant and deter other companies from acting similarly.<br>Why Are Lawsuits Becoming Filed?<br><br>Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege severe and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.<br><br>In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:<br><br>The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.<br>The makers of the drug continue to market Xarelto as a secure anticoagulant option.<br>Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.<br>Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.<br>Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.<br><br>Visit this page for much more information on the alleged health risks of Xarelto.<br>Multidistrict Litigation Trial Dates Set<br><br>The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.